PRCS Message Board - Msg: 16353083

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PRCS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Witold who started this subject	9/14/2001 5:10:43 PM
From: sim1	Read Replies (1) of 78

PRAECIS PHARMACEUTICALS INCORPORATED Reschedules Conference Call to Discuss Outcome of FDA Meeting Regarding Plenaxis(TM) WALTHAM, Mass., Sept. 14 /PRNewswire/ -- PRAECIS PHARMACEUTICALS INCORPORATED (Nasdaq: PRCS - news) announced today that it has rescheduled its conference call to discuss the outcome of the Company's September 10, 2001 meeting with the U.S. Food and Drug Administration regarding its New Drug Application for PLENAXIS(TM) for the treatment of hormonally responsive prostate cancer. PRAECIS will hold its conference call at 9:00 a.m. Eastern Time on Monday, September 17, 2001. Interested investors and others may listen to the call live by calling 888-857-6929 or 719-457-2600. This call may also be accessed by visiting PRAECIS' website at praecis.com and clicking on the ``Investor Relations'' icon. The webcast will be available for replay on PRAECIS' website for a period of one week after the conference call.<snip>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next